Original Article
Meta-analysis of a master mimicker: endobronchial lipoma
Chinese Clinical Oncology
2020;
9
(2)
:11
.
(17 April 2020)
The value of sonographically guided fine-needle aspiration in the diagnosis of small lymph
Chinese Clinical Oncology
2020;
9
(2)
:12
.
(17 April 2020)
Long term control stereotactic body radiotherapy (SBRT) for oligometastatic colorectal cancer: a single center study
Chinese Clinical Oncology
2020;
9
(2)
:13
.
(17 April 2020)
Effects of a metallic implant on radiotherapy planning treatment—experience on a human cadaver
Chinese Clinical Oncology
2020;
9
(2)
:14
.
(17 April 2020)
Efficacy of cyclophosphamide, doxorubicin, and cisplatin for adenoid cystic carcinoma, and their relationship with the pre-chemotherapy tumor growth rate
Chinese Clinical Oncology
2020;
9
(2)
:15
.
(17 April 2020)
A retrospective study of immune checkpoint inhibitor-associated myocarditis in a single center in China
Chinese Clinical Oncology
2020;
9
(2)
:16
.
(17 April 2020)
Review Article
A narrative review of tropisetron and palonosetron for the control of chemotherapy-induced nausea and vomiting
Chinese Clinical Oncology
2020;
9
(2)
:17
.
(17 April 2020)
State of art and advances on the treatment of bone metastases from breast cancer: a concise review
Chinese Clinical Oncology
2020;
9
(2)
:18
.
(17 April 2020)
Prediction of Immune checkpoint inhibitors benefit from routinely measurable peripheral blood parameters
Chinese Clinical Oncology
2020;
9
(2)
:19
.
(17 April 2020)
Sarcoma MDT Series1
Multidisciplinary sarcoma tumor board: retroperitoneal liposarcoma
Chinese Clinical Oncology
2020;
9
(2)
:20
.
(17 April 2020)
Case Report
A colonic metastasis from extrahepatic cholangiocarcinoma after removal of primary tumor: a case report and literature review
Chinese Clinical Oncology
2020;
9
(2)
:21
.
(17 April 2020)
Editorial Commentary
Bendamustine plus rituximab: is it a BRIGHT idea?
Chinese Clinical Oncology
2020;
9
(2)
:22
.
(17 April 2020)
Combination immunotherapy in metastatic urothelial cancer: time for the next step?
Chinese Clinical Oncology
2020;
9
(2)
:23
.
(17 April 2020)
Carcinomatosis in gastric cancer: the potential for cytoreductive surgery and intraperitoneal chemotherapy
Chinese Clinical Oncology
2020;
9
(2)
:24
.
(17 April 2020)
News
Application of the CARE guideline as reporting standard in the Chinese Clinical Oncology
Chinese Clinical Oncology
2020;
9
(2)
:25
.
(17 April 2020)
Disclosure:
1. The series “Sarcoma MDT Series” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. William Tseng served as the unpaid Guest Editor for the series.